Monitor for future prospectus supplements that will disclose actual offering terms, size, and pricing, these may trigger stock price movement due to potential dilution or capital infusion.
CRIS drugs
CRIS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 23 $0.7400entry
- T+1 · 8mo ago −2.70%α −2.35% · $0.7200
- T+5 · 8mo ago −31.08%α −27.52% · $0.5100
- T+20 · 7mo ago −18.92%α −26.34% · $0.6000
- T+60 · 5mo ago −45.14%α −58.19% · $0.4060
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Curis Inc. (CRIS) has had a registration statement on Form S-3 become effective, allowing the company to issue unspecified securities from time to time. This is a shelf registration, enabling future capital raises without additional SEC approval.
Key Facts
- Form S-3 shelf registration has become effective as of March 20, 2026.
- Registration allows for the issuance of unspecified amounts of securities, including common stock, preferred stock, warrants, or debt.
- No specific offering size, pricing, or use of proceeds disclosed in this filing.
- Company can now access capital markets quickly under this shelf, subject to market conditions.
Financial Impact
Not specified
Risk Factors
- Potential for future dilution if common stock is issued.
- Market perception of equity overhang could pressure shares if no immediate use of proceeds is communicated.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000885 |
| Document: 9999999995-26-000885-index.html | 9999999995-26-000885 |
| Document: 9999999995-26-000885.txt | 9999999995-26-000885 |
Track record
18 reports on CRIS
7 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
- Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
- Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
- Nov 2, 202614d ago DEF 14A Neutral 4/10 Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
- Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers